Industry Portals
Biotechnical Industry News
Integer a velit nec risus malesuada imperdiet id et odio. Nunc sit amet mauris dapibus, feugiat diam eget, suscipit, nam gravida nulla eget turpis commodo.
Dr. Spielberg, former Deputy Commissioner of the FDA, joins Young & Partners (June 11, 2018)
Young & Partners adds to its deep regulatory and biopharma expertise
Banker: Value of Closed M&A Soars in 2017 due to Mega Deals (Feb 12 – 19, 2018, Chemical Week)
Peter Young of Young & Partners interviewed about the nuances of the Chemical M&A market in 2017
Stock Market and Financing – Strong with a Twist (ICIS Chemical Business, Feb 2, 2018 issue)
2017 was great for chemical stock market performance and financing, but not for everyone
Pharma and Biotech: Strategic, M&A and Financial Yearend Review and Outlook (Pharma Exec Feb 2018 issue)
Young & Partners reviews what happened in 2017, the future outlook and the implications for management
Chemical M&A – Below the Surface (ICIS Chemical Business, Jan 26, 2018 issue)
Young & Partners looks at the big picture trends and the nuances underneath
Chemical M&A and IPOs – A Warped View – Young & Partners (ICIS Chemical Business Nov. 10 – 16, 2017 issue)
Amid talk of a hot M&A market and IPOs, if you take a hard look at the numbers, reality is different
The Highs, Lows and the Unexpected – Young & Partners (ICIS Chemical Business Sept 8 – 14, 2017 issue)
Young & Partners' observations about chemical industry's stock market performance and financings (debt and equity)
Pharma and Biotech Markets (Young & Partners article in Pharma Executive eBook) Sept 2017
Young & Partners examines the biopharma stock market and M&A trends and their implications
Fire and Ice – Chemical Mergers and Acquisitions- Young & Partners (ICIS Chemical Business Sept 1 -7, 2017 issue)
While the M&A dollar volume is hot, a look behind the numbers shows that not everything is, or will be
Calm Before The Storm – Young & Partners (ICIS Chemical Business May 19 – 25, 2017 issue)
First Quarter M&A volume was modest, but we are heading for a monster year in M&A in terms of dollar volume
Pharma and Biotech Markets – Mostly Sunny, But An Uncertain Forecast (Pharmaceutical Executive May 9, 2017)
Peter Young offers a summary of the strategic, stock market, M&A and financing issues facing the biopharma industry
Peter Young – Chemical Heritage Foundation Bolte Award (2017)
Chemical Heritage to give the Richard J. Bolte Sr. Award to Peter Young of Young & Partners on Heritage Day
In M&A, Now You See It, Now You Don’t – Young & Partners ICIS Chemical Business Feb 24, 2017 issue)
Young & Partners presents its contrarian analysis of what happened last year in global M&A and the outlook.
Chemical Financing Hits Record Levels – Young & Partners (ICIS Chemical Business Feb 17, 2017 Issue)
Young & Partners analyzes the record dollar value of debt and equity financing in chemicals
Pharma and Biotech Markets – Challenges and Opportunities (Pharma Exec January 2017 Issue)
Peter Young examines what is happening in the M&A and Equity Financing Markets and the Implications for Management
A Fireside Chat with Dr. Stephen Miller (Pharmaceutical Executive Magazine Nov 30, 2016)
Peter Young interviews Dr. Stephen Miller of Express Scripts about his career and industry thoughts
Chemical Week – M&A Moderates Despite Announced Mega Deals (November 28, 2016)
Editor-in-Chief interviews Young & Partners about M&A market slowdown and shift to Asia